Boehringer Ingelheim selects MicroStrategy software to improve sales reporting and efficiency

MicroStrategy((R)) Incorporated (Nasdaq: MSTR), a leading worldwide provider of business intelligence (BI) software, today announced that Boehringer Ingelheim (Schweiz) GmbH (named here as Boehringer Switzerland) has selected MicroStrategy to improve its sales reporting and efficiency. Boehringer Switzerland is the Swiss branch of the international pharmaceuticals company Boehringer Ingelheim.

Boehringer Switzerland selected MicroStrategy for reporting and analysis of sales productivity data. With MicroStrategy, sales data can now be supplied more rapidly to field sales and management, which helps the company to streamline operations. With MicroStrategy's flexible, user-friendly reports, individual users can create their own reports and work more efficiently. In addition, the reports give Boehringer Switzerland management greater insights into market data to help them plan sales activity and analyze the productivity of regional sales groups.

As part of its extensive selection process, the Boehringer Switzerland management team defined 10 Key Performance Indicators and asked selected BI providers to create several reports with this information. "MicroStrategy made an excellent impression during our evaluation process. In addition, our team in Australia has already deployed MicroStrategy for reporting and has had positive results," said Mr. Gregor Brunner, Department Manager IT of Boehringer Switzerland.

"MicroStrategy provides greater reporting capabilities than other BI suppliers and is very user-friendly," explained Alexander Herter, Business Analyst at Boehringer Switzerland and Project Manager for the evaluation of the new BI solution. "Data can be supplied rapidly and more clearly with MicroStrategy, and the reports serve as a basis for operational and strategic decisions."

"We are pleased to have the Swiss branch of Boehringer Ingelheim, one of the world's leading pharmaceutical companies, as our new customer," said Sanju Bansal, MicroStrategy's COO.

Source: http://www.microstrategy.com

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Sapio Sciences Collaborates with Waters Corporation to Improve Efficiency of Laboratory Operations